Br J Anaesth:甲状腺功能亢进患者围手术期甲状腺风暴的风险

2021-10-19 从医路漫漫 MedSci原创

背景:甲状腺风暴是甲状腺机能亢进患者手术中一个可怕的并发症。我们评估了原发性甲状腺机能亢进手术患者不同术前治疗方案发生甲状腺风暴的风险。

背景:甲状腺风暴是甲状腺机能亢进患者手术中一个可怕的并发症。我们评估了原发性甲状腺机能亢进手术患者不同术前治疗方案发生甲状腺风暴的风险。

方法:系统检索Pubmed、EMBASE和Cochrane Library中所有关于在全身麻醉下接受选择性手术的成人甲状腺功能亢进患者的研究。选择的研究根据术前治疗进行分类:无治疗、抗甲状腺药物(硫酰胺类)、碘、β受体阻断药物或其联合用药。治疗效果,即恢复甲状腺功能正常,如果有的话,从文献中摘录。使用非随机化干预研究中的偏倚风险(Robins-I)或随机研究的Cochrane偏倚风险工具来评估偏倚风险。

结果:搜索产生了7009篇文章,其中26篇发表于1975年至2020年的研究被选中进行批判性评价。所有研究均存在中度至临界偏倚风险,主要原因是混淆风险、干预状态分类和结果定义。所有的研究都报道了甲状腺切除术患者。我们没有发现在治疗和未治疗患者之间比较甲状腺风暴风险的随机研究。所有治疗组均报告甲状腺风暴病例,其发生率从0%至14%不等。

表1 Burch和Wartofsky评分系统。≥45分高度提示甲状腺风暴;25-44的分数提示可能产生甲状腺风暴,而低于25的分数代表不太可能出现甲状腺风暴。

表2 总体结果。纳入研究中甲状腺风暴发生率的概述。对每项研究的作者、发表年份、纳入患者的数量、术前治疗、甲状腺风暴的发生和死亡率进行了描述。如果未报告接受过某种治疗的患者数量已在此表中注明。*这些数字是根据正文重建的,但在原文中没有明确给出,因此在估计它们时可能会有错误。y正文中没有给出甲状腺风暴的诊断,但描述了甲状腺毒症的严重程度增加,症状有出汗、精神混乱、激动、心动过速和发烧。由于没有给出任何值,BurcheWartofsky的得分无法估计。

结论:这是第一次对文献进行综述,概述目前有关甲亢患者围手术期甲状腺风暴风险的现有证据。尽管这篇综述涵盖了所有相关文献,但研究设计和纳入研究的都存在一些局限性,因此评估围手术期甲状腺风暴风险的证据是不充分的。鉴于这种并发症的严重性和不可能确定风险增加的患者,这些患者的术前治疗仍然是必要的。

原文出处:

de Mul N,  Damstra J,  Nieveen van Dijkum EJM,et al.The risk of perioperative thyroid storm in hyperthyroid patients: a systematic review.Br J Anaesth 2021 Aug 10

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2051712, encodeId=2b502051e1252, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Tue Aug 16 04:01:10 CST 2022, time=2022-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1633617, encodeId=98c5163361e21, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Mon Jan 24 12:01:10 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2053925, encodeId=9ee12053925b0, content=<a href='/topic/show?id=8f5a54442a1' target=_blank style='color:#2F92EE;'>#手术期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54442, encryptionId=8f5a54442a1, topicName=手术期)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WQ1WyMBGic8d2fKdCe6Cm3vaRh4X8YnlumYndC46iagNCBl9Df8RtoCaQchnFtZldHUctGJjsgsyutUlu8vPq6yQ/132, createdBy=97862500016, createdName=ms3117646317107274, createdTime=Wed Aug 24 21:01:10 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273723, encodeId=6cb112e3723f9, content=<a href='/topic/show?id=10a5698555f' target=_blank style='color:#2F92EE;'>#甲状腺功能亢进#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69855, encryptionId=10a5698555f, topicName=甲状腺功能亢进)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a19115, createdName=stfoxst, createdTime=Wed Oct 20 14:01:10 CST 2021, time=2021-10-20, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2051712, encodeId=2b502051e1252, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Tue Aug 16 04:01:10 CST 2022, time=2022-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1633617, encodeId=98c5163361e21, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Mon Jan 24 12:01:10 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2053925, encodeId=9ee12053925b0, content=<a href='/topic/show?id=8f5a54442a1' target=_blank style='color:#2F92EE;'>#手术期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54442, encryptionId=8f5a54442a1, topicName=手术期)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WQ1WyMBGic8d2fKdCe6Cm3vaRh4X8YnlumYndC46iagNCBl9Df8RtoCaQchnFtZldHUctGJjsgsyutUlu8vPq6yQ/132, createdBy=97862500016, createdName=ms3117646317107274, createdTime=Wed Aug 24 21:01:10 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273723, encodeId=6cb112e3723f9, content=<a href='/topic/show?id=10a5698555f' target=_blank style='color:#2F92EE;'>#甲状腺功能亢进#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69855, encryptionId=10a5698555f, topicName=甲状腺功能亢进)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a19115, createdName=stfoxst, createdTime=Wed Oct 20 14:01:10 CST 2021, time=2021-10-20, status=1, ipAttribution=)]
    2022-01-24 AspirantSuo
  3. [GetPortalCommentsPageByObjectIdResponse(id=2051712, encodeId=2b502051e1252, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Tue Aug 16 04:01:10 CST 2022, time=2022-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1633617, encodeId=98c5163361e21, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Mon Jan 24 12:01:10 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2053925, encodeId=9ee12053925b0, content=<a href='/topic/show?id=8f5a54442a1' target=_blank style='color:#2F92EE;'>#手术期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54442, encryptionId=8f5a54442a1, topicName=手术期)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WQ1WyMBGic8d2fKdCe6Cm3vaRh4X8YnlumYndC46iagNCBl9Df8RtoCaQchnFtZldHUctGJjsgsyutUlu8vPq6yQ/132, createdBy=97862500016, createdName=ms3117646317107274, createdTime=Wed Aug 24 21:01:10 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273723, encodeId=6cb112e3723f9, content=<a href='/topic/show?id=10a5698555f' target=_blank style='color:#2F92EE;'>#甲状腺功能亢进#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69855, encryptionId=10a5698555f, topicName=甲状腺功能亢进)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a19115, createdName=stfoxst, createdTime=Wed Oct 20 14:01:10 CST 2021, time=2021-10-20, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2051712, encodeId=2b502051e1252, content=<a href='/topic/show?id=95f8e042dd' target=_blank style='color:#2F92EE;'>#EST#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=7042, encryptionId=95f8e042dd, topicName=EST)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Tue Aug 16 04:01:10 CST 2022, time=2022-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1633617, encodeId=98c5163361e21, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2471, encryptionId=377824e1c0, topicName=ANA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=434d22047430, createdName=AspirantSuo, createdTime=Mon Jan 24 12:01:10 CST 2022, time=2022-01-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2053925, encodeId=9ee12053925b0, content=<a href='/topic/show?id=8f5a54442a1' target=_blank style='color:#2F92EE;'>#手术期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54442, encryptionId=8f5a54442a1, topicName=手术期)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/WQ1WyMBGic8d2fKdCe6Cm3vaRh4X8YnlumYndC46iagNCBl9Df8RtoCaQchnFtZldHUctGJjsgsyutUlu8vPq6yQ/132, createdBy=97862500016, createdName=ms3117646317107274, createdTime=Wed Aug 24 21:01:10 CST 2022, time=2022-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1273723, encodeId=6cb112e3723f9, content=<a href='/topic/show?id=10a5698555f' target=_blank style='color:#2F92EE;'>#甲状腺功能亢进#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69855, encryptionId=10a5698555f, topicName=甲状腺功能亢进)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a19115, createdName=stfoxst, createdTime=Wed Oct 20 14:01:10 CST 2021, time=2021-10-20, status=1, ipAttribution=)]

相关资讯

McCune-Albright综合征伴甲状腺功能亢进1例

女,33岁,因“右颊部肿物5年余”入院。患者5年前发现右侧颊部肿物,无明显诱因,疼痛不明显,最近数月生长加速,约鸡蛋大小。自述上颌骨渐进性肿大20余年,一直未接受治疗。2008年曾因甲状腺功能亢进于当地医院行甲状腺部分切除术。患者家属诉其出生后数月大腿出现片状棕灰色斑块。患者足月产2胎,均存活。月经初潮年龄12岁,每次5d,周期30d。否认家族中有类似病史。

这例甲状腺功能亢进症为什么漏诊了?因为未透过现象看本质……

患者,男,29岁。因“发作性双下肢无力1个月,加重2小时”就诊。

Epidemiology:尿双酚A或增高国人甲亢风险

  动物实验发现双酚A可与甲状腺激素受体结合从而影响甲状腺功能,但这种关联性研究尚未在人群中展开。为了探讨中国人群中尿双酚A与甲状腺功能的关系,我国上海交通大学医学院附属瑞金医院宁光教授开展了一项横断面研究。研究发现,高水平的尿双酚A与甲状腺功能亢进相关。研究于2013年1月18日在线发表于《流行病学》(Epidemiology)杂志。   该研究在上海市宝山区淞南社区招募志愿者,从2009年1

Br J Surg:治疗三发性甲状旁腺功能亢进症 手术还是药物?

甲状旁腺功能亢进症病因为肾上腺皮质增生或腺瘤引起的甲状旁腺素分泌过多,可分为原发性、继发性、三发性三种。2017年6月,发表在《Br J Surg》的一项由荷兰科学家进行的系统评价,考察了手术和药物治疗三发性甲状旁腺功能亢进症的疗效。

Medicine:眼眶减压术对甲状腺功能亢进视神经病变的影响

广西医科大学第一附属医院眼科的Liang QW和中山大学眼科中心的Yang H等人近日在Medicine杂志上发表了一项最新研究进展,他们尝试探讨了眼眶减压治疗对严重甲状腺功能亢进视神经病变的影响。